Tag: regulatory compliance

Aligning Device & Diagnostic Transparency With ICH, GCP and Transparency Regulations In the evolving landscape of clinical trials, the need for transparency in device and diagnostic studies has become a focal point for regulatory bodies across the globe. This detailed tutorial aims to guide clinical operations, regulatory affairs, and medical affairs professionals in understanding how…

Read More “Aligning Device & Diagnostic Transparency With ICH, GCP and Transparency Regulations” »

Device & Diagnostic Transparency Playbook for High-Profile and Late-Phase Trials Device & Diagnostic Transparency Playbook for High-Profile and Late-Phase Trials Introduction to Clinical Trial Transparency In the realm of clinical research, particularly involving high-profile and late-phase trials, transparency is paramount. This holds true for medical devices and diagnostics, where the expectations of regulatory agencies such…

Read More “Device & Diagnostic Transparency Playbook for High-Profile and Late-Phase Trials” »

Device & Diagnostic Transparency in Practice: Step-by-Step Guide for Sponsors and CROs Device & Diagnostic Transparency in Practice: Step-by-Step Guide for Sponsors and CROs Clinical trials are critical in the development and approval of medical devices and diagnostics. Ensuring transparency in these trials is not only a regulatory requirement but also vital to maintain public…

Read More “Device & Diagnostic Transparency in Practice: Step-by-Step Guide for Sponsors and CROs” »

Common Pitfalls in Device & Diagnostic Transparency—and How to Avoid Costly Findings Common Pitfalls in Device & Diagnostic Transparency—and How to Avoid Costly Findings Transparency in clinical trials is crucial, especially concerning devices and diagnostics. It not only ensures compliance with regulatory standards but also fosters trust among stakeholders, including patients, researchers, and regulatory authorities….

Read More “Common Pitfalls in Device & Diagnostic Transparency—and How to Avoid Costly Findings” »

Device & Diagnostic Transparency: Compliance Strategy for US, EU and UK Clinical Programs Device & Diagnostic Transparency: Compliance Strategy for US, EU and UK Clinical Programs In an increasingly regulated environment for clinical trials, ensuring transparency in device and diagnostic development has become a paramount responsibility for clinical operations, regulatory affairs, and medical affairs professionals….

Read More “Device & Diagnostic Transparency: Compliance Strategy for US, EU and UK Clinical Programs” »

How to Design Device & Diagnostic Transparency That Meets FDA, EMA and MHRA Expectations How to Design Device & Diagnostic Transparency That Meets FDA, EMA and MHRA Expectations Introduction to Clinical Trial Transparency Transparency in clinical trials is crucial for regulatory compliance and ethical research practices. In the context of medical devices and diagnostics, regulatory…

Read More “How to Design Device & Diagnostic Transparency That Meets FDA, EMA and MHRA Expectations” »